Research location
Hattingen
Germany
Advertisement
Research activity in Hattingen
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 18 trials and 19 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Hattingen
18 linked trials · page 1 of 1REported Outcomes in COPD With Trixeo in Real worlD in GermanyNCT05311306 · 2022-03-15 · 1 site observation
COMPLETED
Comparison of the Effectiveness of Two Different Dosages of Cortisone Compared to Placebo in Rheumatoid ArthritisNCT02000336 · 2014-01-01 · 2 site observations
COMPLETED
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentNCT01838681 · 2013-06-01 · 1 site observation
COMPLETED
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake InhibitorNCT01185340 · 2011-03-01 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 1 site observation
COMPLETED
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on DonepezilNCT00829374 · 2009-03-01 · 1 site observation
COMPLETED
Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive DisorderNCT00844194 · 2009-02-01 · 1 site observation
COMPLETED
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD PatientsNCT00789854 · 2008-11-01 · 1 site observation
COMPLETED
A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's DiseaseNCT00679627 · 2008-06-01 · 1 site observation
TERMINATED
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to RisperidoneNCT00600756 · 2008-01-01 · 1 site observation
COMPLETED
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With SchizophreniaNCT00460512 · 2007-04-25 · 1 site observation
COMPLETED
Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's DiseaseNCT00539214 · 2007-03-01 · 1 site observation
COMPLETED
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesNCT00539487 · 2007-01-01 · 1 site observation
COMPLETED
A Switch Study of BMS-337039 in Schizophrenic Out-patientsNCT00232687 · 2005-06-01 · 1 site observation
COMPLETED
A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainNCT00191919 · 2005-05-01 · 1 site observation
COMPLETED
Schizophrenia Trial of AripiprazoleNCT00237913 · 2004-07-01 · 1 site observation
COMPLETED
Post-marketing Observational Study in Subjects With Rheumatoid ArthritisNCT00234884 · 2003-09-01 · 1 site observation
COMPLETED
Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical PracticeNCT01078090 · 2003-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.